Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

How is cancer-related venous thromboembolism treated in real world practice?

Prof Alok Khorana - Cleveland Clinic, Cleveland, USA

How is cancer-related venous thromboembolism treated in real world practice? ( Prof Alok Khorana - Cleveland Clinic, Cleveland, USA )

Dalteparin thromboprophylaxis for cancer patients at high risk of venous...

Prof Alok Khorana - Cleveland Clinic, Cleveland, USA

Dalteparin thromboprophylaxis for cancer patients at high risk of venous thromboembolism ( Prof Alok Khorana - Cleveland Clinic, Cleveland, USA )

Response to rituximab induction is a predictive biomarker in post-transplant...

Prof Corrado Tarella - Istituto Europeo di Oncologia, Milano, Italy

Response to rituximab induction is a predictive biomarker in post-transplant lymphoproliferative disorder ( Prof Corrado Tarella - Istituto Europeo di Oncologia, Milano, Italy )

“Low but real” risk of myelodysplastic syndromes caused by thyroid cancer...

Dr Sudipto Mukherjee - Cleveland Clinic, Cleveland, USA

“Low but real” risk of myelodysplastic syndromes caused by thyroid cancer treatment ( Dr Sudipto Mukherjee - Cleveland Clinic, Cleveland, USA )

High dose chemotherapy plus transplant remains standard care for young newly...

Dr Francesca Gay - University of Torino, Torino, Italy

High dose chemotherapy plus transplant remains standard care for young newly diagnosed multiple myeloma patients ( Dr Francesca Gay - University of Torino, Torino, Italy )

ENDEAVOR: carfilzomib new standard in multiple myeloma?

Dr Keith Stewart - Mayo Clinic, Rochester, USA

ENDEAVOR: carfilzomib new standard in multiple myeloma? ( Dr Keith Stewart - Mayo Clinic, Rochester, USA )

How can functional drug screening guide personalised cancer therapy?

Prof Jeff Tyner - Oregon Health & Science University, Portland, USA

How can functional drug screening guide personalised cancer therapy? ( Prof Jeff Tyner - Oregon Health & Science University, Portland, USA )

How do genes influence the development of chronic idiopathic thrombocytopenic...

Prof Jenny Despotovic - Texas Children's Cancer Center, Houston, USA

How do genes influence the development of chronic idiopathic thrombocytopenic purpura? ( Prof Jenny Despotovic - Texas Children's Cancer Center, Houston, USA )

Combining treatment options for higher risk myelodysplastic syndromes and...

Dr Mikkael Sekeres - Cleveland Clinic Foundation, Cleveland, USA

Combining treatment options for higher risk myelodysplastic syndromes and chronic myelomonocytic leukaemia ( Dr Mikkael Sekeres - Cleveland Clinic Foundation, Cleveland, USA )

ASH 2015: Highlights in mantle cell lymphoma

Prof Simon Rule and Prof Steven Le Gouill

ASH 2015: Highlights in mantle cell lymphoma ( Prof Simon Rule and Prof Steven Le Gouill )

Incidence of and predictors for early death in paediatric patients with acute...

Dr Oussama Abla - The Hospital for Sick Children, Toronto, Canada

Incidence of and predictors for early death in paediatric patients with acute promyelocytic leukaemia ( Dr Oussama Abla - The Hospital for Sick Children, Toronto, Canada )

Blinatumomab has promising effect on hard-to-treat, rare acute lymphoblastic...

Prof Giovanni Martinelli - University of Bologna, Bologna, Italy

Blinatumomab has promising effect on hard-to-treat, rare acute lymphoblastic leukaemia subtype ( Prof Giovanni Martinelli - University of Bologna, Bologna, Italy )

More from ecancer